direkt zum Inhalt springen

direkt zum Hauptnavigationsmenü

Sie sind hier

TU Berlin

Page Content

2021 [1] |2020 [2] | 2019 [3] | 2018 [4] | 2017 [5] | 2016 [6] | 2015 [7] | 2014 [8] | 2013 [9] | 2012 [10] | 2011 [11] | 2010 [12] | 2009 [13] | 2008 [14] | 2007 [15] | 2006 [16] | 2005 [17] | 2004 [18] | 2003 [19] | 2002 [20]

Lectures 2014

Lupe [21]
Lupe [22]

Diagnosis Related Groups in Europe: Adaptations and trends [23]
Diagnosis Related Groups en Europe: Adaptations et tendances [24]
W. Quentin
Genf 26.11.2014

“Living up to Improved Performance” - The role of international projects [25]
Britta Zander
Eupha 22.11.2014

Lupe [26]

Provision of health services: Trends and patterns in Europe (EU 28 + Iceland, Norway and Switzerland) [27]
W. Quentin, J. Cylus, A. Geissler, A. Maresso, S. Merkur, G. Pastorino, A. Sagan
Glasgow 21.11.2014

Lupe [28]

Hospital payment and Diagnosis - Related Groups in Germany - Boone or Bane? [29]
Alexander Geissler, Dr.
Dubrovnik 14.11.2014

Lupe [30]

DRGs: Are hospitals paid for what they do – or do they do for what they are paid? And why patients should care about it [31]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Doha 21.10.2014

Lupe [32]

Medical devices: a taxonomy suitable for HTA [33]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warsaw, 26.09.2014

Lupe [34]

Medical devices: differences vs. other technologies, especially pharmaceuticals [35]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warsaw, 26.09.2014

Lupe [36]

Inequalities in Health and Health Care [37]
Martin Siegel, Dr.
Dresden 22.09.2014

Lupe [38]

Exploring barriers and dilemmas for the adoption of cost containment strategies in the economic, institutional and political environment [39]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brussels 17.09.2014

Lupe [40]

The German health system: basics and some comparisons with other countries [41]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 16.09.2014

Lupe [42]

From a conservative to a liberal welfare state: decomposing changes in income-related health inequalities in Germany, 1994-2011 [43]
Martin Siegel, Dr.
Dublin 16.07.2014

Lupe [44]

Towards a taxonomy of medical devices in the logic of HTA and economic evaluations rather than marketing authorization [45]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 15.07.2014

A taxonomy of medical devices in the logic of HTA [46]
Dimitra Panteli
Washington 16.06.2014

Equity considerations among HTA agencies –current practice and ways forward [47]
Dimitra Panteli
Washington 16.06.2014

The role of dissemination bias in pharmaceutical coverage decisions: an analysis of practices in European countries [48]
Dimitra Panteli
Washington 16.06.2014

The process of evidence-based decision-making for the reimbursement and pricing of pharmaceuticals in Europe: mapping approaches in 36 countries [49]
Dimitra Panteli
Washington 16.06.2014

Lupe [50]

Intoduction to the healthcare ecosystem and cost factors [51]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 05.05.2014

Lupe [52]

The Health Systems and Policy Monitor (HSPM) [53]
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 29.04.2014

Lupe [54]

The European Observatory on Health Systems and Policies [55]
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 28.04.2014

Lupe [56]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (II) [57]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [58]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (I) [59]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [60]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview [61]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 14.04.2014

Lupe [62]

Health care reform and pharmaceutical policies in Germany [63]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [64]

Addressing emerging patient needs:from free choice to integrated care [65]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brussels 21.03.2014

Lupe [66]

Hospital payment and DRGs in Germany: The G-DRG system [67]
Wilm Quentin, Dr. med MSc HPPF
Warsaw 18.03.2014

Lupe [68]

The effect of continuity of ambulatory care on hospitalizations in patients with heart failure [69]
Verena Vogt
Munich 17.03.2014

Lupe [70]

The Latvian Health System [71]
Uldis Mittenbergs & Wilm Quentin
Brussels 07.03.2014

Lupe [72]

Regulation and governance of providers (especially hospitals) [73]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014

Lupe [74]

DRGs in Europe: towards transparency, efficiency, and quality of hospital care? [75]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014

Lupe [76]

Implementing competitive UHI: benefit basket, pooling, risk-related allocation and other important considerations [77]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 23.01.2014

Lupe [78]

The financing function: Raising, pooling and allocating resources [79]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

Lupe [80]

Differences in health care structure and incentives – do they worsen or reduce health inequalities? (… and a framework to examine access to health care …) [81]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

Lupe [82]

Health system reforms in times of crisis: EU countries [83]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

------ Links: ------

Zusatzinformationen / Extras

Quick Access:

Schnellnavigation zur Seite über Nummerneingabe

Auxiliary Functions

Copyright TU Berlin 2008